RXRX

NASDAQStock

Recursion Pharmaceuticals, Inc.

$3.40+0.11 (+3.34%)

52-Week Range

$3.29
$6.84

Key Stats

Market Cap

1.5B

P/E Ratio

Dividend Yield

Beta

0.96

Volume

12.4M

Avg Volume

16.7M

Performance

1M

-8.10%

3M

-21.67%

6M

-31.03%

YTD

-21.67%

1Y

-48.19%

3Y

-56.02%

5Y

-89.49%

Price Chart

ETF Exposure

RXRX is held by 118 ETFs

ETFFund NameWeight
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VTVanguard Total World Stock ETF0.00%
XEQT.TOiShares Core Equity ETF Portfolio0.00%
XUU.TOiShares Core S&P U.S. Total Market Index ETF0.00%
AVTMAvantis Total Equity Markets ETF 10.00%
AVUSAvantis U.S. Equity ETF0.00%
DFASDimensional - US Small Cap ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TILTFlexShares Morningstar U.S. Market Factor Tilt Index Fund0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
PreviousPage 3 of 3

About RXRX ETF Exposure

Recursion Pharmaceuticals, Inc. (RXRX) is held by 118 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 1.5B, RXRX is a widely held institutional stock. The stock currently trades at $3.40. Investors can gain exposure to RXRX through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RXRX, sorted by portfolio weight.